Moderna forms oncology collaboration with Carisma Therapeutics
Moderna will collaborate with Penn spinout Carisma Therapeutics to discover, develop and commercialize in-vivo engineered chimeric antigen receptor monocyte therapeutics for the treatment of cancer.
From foundational discoveries to profound impact
Without the mRNA technology foundation laid by Karikó and Weissman, the Pfizer/BioNTech and Moderna vaccines being deployed across the world would not exist.
Technology used in mRNA COVID vaccines offers hope for treatment of millions with heart disease, study suggests
Combining technologies that proved hugely success against cancer and in COVID-19 vaccines, researchers at Penn have shown they can effectively treat a leading cause of heart disease.
Vaccine-like mRNA injection can be used to make CAR T cells in the body
The researchers, whose work is published in Science, demonstrated the new approach with an mRNA preparation that reprograms T cells—a powerful type of immune cell—to attack heart fibroblast cells.
Katalin Karikó, PhD, featured on the cover of Newsweek as one of America’s Greatest Disruptors
She was described as being one of the 50 visionaries whose career-long actions have had far-reaching impact.
Scout Bio licenses new Penn technology to help develop gene therapies for pets
Scout Bio, a Philadelphia company developing gene therapies for animal health, has licensed a new kind of technology from the Penn’s gene therapy program.
Passage Bio further expands Gene Therapy research partnership with Penn
Passage Bio has exercised two additional options for potential new drug candidates under its research collaboration with Penn's gene therapy program.
A chewing gum that could reduce SARS-CoV-2 transmission
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
Celebration of Innovation 2021 Recap and Recording
The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.
Choosing the University of Pennsylvania for Its Excellence: As a Student, a Patient, and Employee
Carter Caldwell, the Director of the Penn Medicine Co-Investment Program, wrote a guest blog for Penn Medicine News on how the University has impacted his life as a student, a patient, and an employee